Journal of Peptide Research · 1998 · 16 citations · 29 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyGastrointestinal PharmacotherapyPharmacodynamicsGastric DiseasesGastrointestinal FunctionGastrointestinal PathophysiologyGastrointestinal PharmacologyAcid Secretion InhibitionGastric Acid-base BalanceGastric Hormonal RegulationGastric Ph RegulationGastric SecretionGastric Secretory PhysiologyGastrin SecretionProton Pump Inhibition
The peptide xenin 25 is a gastric mucosal constituent like gastrin, somatostatin and pepsinogen. Gastrin and pepsinogen plasma concentrations increase when the secretion of gastric acid is reduced by proton pump inhibitors. In the present investigation, treatment with omeprazole led to an increase in fasting and postprandial plasma concentrations of xenin, gastrin and pepsinogens A and C (P < 0.05, in each instance), whereas somatostatin plasma levels remained unchanged. Because subcutaneous injection of pentagastrin did not raise xenin plasma concentrations, a direct effect of gastrin on xenin production seems unlikely. This study indicates that xenin plasma concentrations are regulated by intragastric pH, as are those of gastrin and pepsinogen.
29
Somatostatin Cell Processes as Pathways for Paracrine Secretion
Lars‐Inge Larsson, N. Goltermann, Laura de Magistris et al. · Science · 1979 · 514 citations
Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation
Håkan Larsson, Enar Carlsson, H. Mattsson et al. · Gastroenterology · 1986 · 508 citations
Texicological studies on omeprazole
L. Ekman, Emma Hansson, Niilo Havu et al. · Scandinavian Journal of Gastroenterology · 1985 · 356 citations
Medicine, Pharmacology, Toxicology +16
Long-Term Omeprazole Treatment in Man: Effects on Gastric Endocrine Cell Populations
R. Lamberts, W. Creutzfeldt, F. Stöckmann et al. · Digestion · 2009 · 150 citations